Trial Profile
A phase IIIb/IV, single-center, randomized, controlled, observer-blind study to assess the effects of topical formulations containing clindamycin-benzoyl peroxide on epidermal functions in subjects with healthy skin
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Aug 2012
Price :
$35
*
At a glance
- Drugs Benzoyl peroxide/clindamycin (Primary) ; IDP 110
- Indications Bacterial infections; Skin infections
- Focus Pharmacodynamics
- Sponsors Arcutis Pharmaceuticals
- 24 Apr 2012 New trial record